Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Intermittent Hypoxia Induces Epigenetic Changes and p16-Mediated Senescence in Vascular Dysfunction in Male Mice.

Created on 19 Nov 2026

Authors

Rene Cortese, Kylie Cataldo, Mohammad Badran, Milda Milciute, Juozas Gordevicius, Zhuanhong Qiao, Jonathan Eusey, Abdelnaby Khalyfa, David Gozal

Published in

Sleep. Nov 19, 2026. Epub Nov 19, 2026.

Abstract

Obstructive Sleep Apnea (OSA) is a pervasive cardiovascular risk factor linked to accelerated aging. We investigated the underlying tissue-specific and systemic epigenetic mechanisms and the role of cellular senescence in the pathophysiology of OSA and associated cardiovascular disease (CVD).
C57BL/6J male mice were exposed to intermittent hypoxia (IH) or room air (RA) (n=25 mice/group) for 7 to 210 days. DNA methylation profiling was conducted on left cardiac ventricle and peripheral blood mononuclear cells (PBMCs) and the impact of IH duration was studied using regression models. Epigenetic age acceleration (EAA) was calculated using a multi-tissue epigenetic clock. The role of p16-mediated senescence in IH-induced vascular dysfunction was assessed using transgenic mouse models (n=8 mice/group).
IH exposures increased blood pressure and altered endothelial function in male mice. IH/RA differentially methylated positions (DMPs) were identified in left cardiac ventricle (n=5,747) and PBMCs (n=1,307), with minimal overlap (n=163, p=8.03 x 10-8). Both tissues differed in the EAA trajectory throughout the exposures. Epigenetic changes linked to cardiac dysfunction and cellular senescence, highlighting the Cdkn2a gene (encoding the p16 protein, a marker of cellular senescence). p16 expression was increased in aortic endothelial cells following IH. Systemic ablation of p16-expressing cells reversed IH-induced hypertension and restored coronary flow reserve.
IH induces duration-dependent, tissue-specific epigenetic dysregulation and accelerated biological aging with p16-mediated cellular senescence as a primary driver. Targeting the senescent endothelium can revert OSA-induced vascular dysfunction, thereby establishing a novel mechanistic framework for cellular senescence as a therapeutic target in OSA.

PMID:
43055727
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement